Skip to content
OpenCapital
Get started

CareDx CDNA Accretion (Amortization) of Discounts and Premiums, Investments

Accretion (Amortization) of Discounts and Premiums, Investments at other companies

Veracyte logo
VeracyteVCYT
$614K-30.4%
Guardant Health logo
Guardant HealthGH
——

Other financials

Income statement

See full
Revenue$117.7M+39.0%
Operating income$1.2M+109%
Net income$2.8M+127%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$78.5M-12.1%
Total debt$24.5M-19.1%
Total equity$313.5M-17.3%
Total assets$411.1M-16.0%

Cash flow

See full
Operating cash flow$4.3M+116%
CapEx$3.8M+134%
Free cash flow$514.0K+102%

Valuation

See full
Market cap$1.4B+32.2%
Enterprise value$1.35B+34.6%
P/S3.4×+0.3×

Profitability

See full
Gross margin65.5%—
Operating margin-3.9%-18.3pp
Net margin-2%-19.9pp
FCF margin-0%0.0pp

Returns & leverage

See full
Return on equity-2.4%-21.9pp
Debt / equity0.1×0.0×
Current ratio3.4×-0.7×

Where this comes from

Reported directly by CareDx in its filing.

Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.

The official record: CareDx’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about CareDx's accretion (amortization) of discounts and premiums, investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CareDx's accretion (amortization) of discounts and premiums, investments?
CareDx (CDNA) reported accretion (amortization) of discounts and premiums, investments of -$912K in Q1 2026.
How has CareDx's accretion (amortization) of discounts and premiums, investments changed year-over-year?
CareDx's accretion (amortization) of discounts and premiums, investments decreased by 9.0% year-over-year, from -$837K to -$912K.
What does accretion (amortization) of discounts and premiums, investments mean?
Captures the periodic adjustment to the carrying value of debt or investment securities to reflect the amortization of premiums or accretion of discounts over the instrument's life. This adjustment aligns the effective interest rate with the stated interest rate, impacting non-cash operating results.